130 related articles for article (PubMed ID: 18635926)
1. Pulmonary hypertension in chronic renal failure patients.
Abdelwhab S; Elshinnawy S
Am J Nephrol; 2008; 28(6):990-7. PubMed ID: 18635926
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
Nakhoul F; Yigla M; Gilman R; Reisner SA; Abassi Z
Nephrol Dial Transplant; 2005 Aug; 20(8):1686-92. PubMed ID: 15840664
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in patients with chronic renal failure.
Havlucu Y; Kursat S; Ekmekci C; Celik P; Serter S; Bayturan O; Dinc G
Respiration; 2007; 74(5):503-10. PubMed ID: 17505128
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension.
van Beers EJ; Nur E; Schaefer-Prokop CM; Mac Gillavry MR; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Muskiet FA; Schnog JJ; Biemond BJ;
Am J Hematol; 2008 Nov; 83(11):850-4. PubMed ID: 18819095
[TBL] [Abstract][Full Text] [Related]
5. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension and predisposing factors in patients receiving hemodialysis.
Mousavi SA; Mahdavi-Mazdeh M; Yahyazadeh H; Azadi M; Rahimzadeh N; Yoosefnejad H; Ataiipoor Y
Iran J Kidney Dis; 2008 Jan; 2(1):29-33. PubMed ID: 19367006
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and factors affecting pulmonary hypertension in hemodialysis patients.
Dagli CE; Sayarlioglu H; Dogan E; Acar G; Demirpolat G; Ozer A; Koksal N; Gelen ME; Atilla N; Tanrikulu AC; Isik IO; Ugur T
Respiration; 2009; 78(4):411-5. PubMed ID: 19844134
[TBL] [Abstract][Full Text] [Related]
8. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
[TBL] [Abstract][Full Text] [Related]
9. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension.
Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA
Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405
[TBL] [Abstract][Full Text] [Related]
10. Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure.
Beigi AA; Sadeghi AM; Khosravi AR; Karami M; Masoudpour H
J Vasc Access; 2009; 10(3):160-6. PubMed ID: 19670168
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
[TBL] [Abstract][Full Text] [Related]
12. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Dong H; Chen DQ; Wang Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
14. Arterio-venous access in end-stage renal disease patients and pulmonary hypertension.
Yigla M; Banderski R; Azzam ZS; Reisner SA; Nakhoul F
Ther Adv Respir Dis; 2008 Apr; 2(2):49-53. PubMed ID: 19124358
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
16. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
18. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in dialysis patients.
Oygar DD; Zekican G
Ren Fail; 2012; 34(7):840-4. PubMed ID: 22680782
[TBL] [Abstract][Full Text] [Related]
20. [Effects of maintenance hemodialysis on right ventricular dysfunction in patients with end-stage renal disease].
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):814-8. PubMed ID: 25341347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
